ARHS Arhaus, Inc.
Arhaus, Inc. operates as a premium retailer in the home furnishings market in the United States. The company offers bedroom, dining room, and living room, as well as home office furnishings, including sofas, dining tables and chairs, accent chairs, console and coffee tables, beds, headboards, dressers, desks, bookcases, modular storage, and other items; and outdoor products, such as outdoor dining tables, chairs, chaises and other furniture, lighting, textiles, décor, umbrellas, and fire pits. It also provides bath product assortment comprising vanities and storage pieces, faucets and hardware, and Turkish bath towels; lighting fixtures, including chandeliers, pendants, table and floor lamps, and sconces; indoor and outdoor rugs, bed linens, and pillows and throws; and décor products, such as wall art, mirrors, vases, candles, and other decorative accessories. The company distributes its products through an omni-channel model comprising showrooms, ecommerce, catalogs and digital media, interior designer services, trade services, and client engagement. Arhaus, Inc. was founded in 1986 and is headquartered in Boston Heights, Ohio.…
Industry Peers
Specialty RetailKey Statistics
About Arhaus (NASDAQ: ARHS)
›
Arhaus (NASDAQ: ARHS) is listed on Nasdaq, where its shares trade in USD. It belongs to the Specialty Retail industry, part of the Consumer Cyclical sector, and reports about 2,700 employees.
The shares were at 13.00 USD on 20 November 2026, up 38.6% over 52 weeks. Its 52-week range is 5.570 USD to 15.17 USD: the price is 14.3% below the high and 133.4% above the low.
At a market capitalisation of 1.84B USD, it trades at 28.3 times trailing earnings and 21.9 times forward earnings. The median trailing P/E of its 20 largest Specialty Retail peers is 16.6, a premium of 71% for ARHS.
Arhaus reports return on equity of 16.1%, an operating margin of 5.2% and revenue up 6.8% year over year.
Its debt exceeds its cash by 306.48M USD, a debt-to-equity ratio of 1.39. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 13 analysts cover the stock, with an average rating of Buy; their mean price target of 14.15 USD is 8.9% above the current price. The next earnings report is expected on 25 February 2027.